Prince Pharmaceutical Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1,041	802	1,267	-	-	-
Market Cap Growth	20.04%	-36.72%	-	-	-	-
Enterprise Value	1,405	1,180	1,670	-	-	-
Last Close Price	28.45	21.90	34.68	-	-	-
PE Ratio	-	-	82.75	-	-	-
PS Ratio	1.30	1.16	1.68	-	-	-
PB Ratio	1.41	1.11	1.64	-	-	-
P/TBV Ratio	1.41	1.11	1.64	-	-	-
P/FCF Ratio	34.20	28.42	2827.58	-	-	-
P/OCF Ratio	25.74	17.35	20.27	-	-	-
EV/Sales Ratio	1.76	1.71	2.22	-	-	-
EV/EBITDA Ratio	21.59	259.75	21.99	-	-	-
EV/EBIT Ratio	-	-	64.79	-	-	-
EV/FCF Ratio	46.15	41.83	3728.36	-	-	-
Debt / Equity Ratio	0.60	0.64	0.63	0.80	0.94	0.86
Debt / EBITDA Ratio	6.77	35.06	5.81	4.35	12.80	-
Debt / FCF Ratio	14.47	16.33	1094.55	7.25	409.55	-
Net Debt / Equity Ratio	0.49	0.50	0.48	0.69	0.82	0.77
Net Debt / EBITDA Ratio	6.46	78.80	4.84	3.97	12.32	-17.65
Net Debt / FCF Ratio	11.95	12.69	820.97	6.26	357.09	-2.51
Asset Turnover	0.59	0.50	0.56	0.55	0.35	0.25
Inventory Turnover	4.38	4.33	4.11	3.68	2.79	2.29
Quick Ratio	0.92	0.94	1.09	0.76	0.67	0.61
Current Ratio	1.63	1.56	1.85	1.59	1.37	1.14
Return on Equity (ROE)	-1.47%	-7.16%	2.14%	8.18%	-1.37%	-5.49%
Return on Assets (ROA)	0.11%	-2.24%	1.19%	3.26%	-0.06%	-2.65%
Return on Invested Capital (ROIC)	0.21%	-4.44%	1.83%	4.93%	-0.10%	-5.03%
Return on Capital Employed (ROCE)	0.20%	-4.40%	2.20%	6.10%	-0.10%	-4.90%
Earnings Yield	-1.05%	-6.68%	1.21%	-	-	-
FCF Yield	2.92%	3.52%	0.03%	-	-	-
Dividend Yield	-	-	0.72%	-	-	-
Payout Ratio	-	-	35.46%	-	-	-
Buyback Yield / Dilution	-0.34%	-0.09%	-9.66%	-0.41%	-1.45%	-2.07%
Total Shareholder Return	-0.34%	-0.09%	-8.94%	-0.41%	-1.45%	-2.07%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.